How Opioid Peptides Respond to Mental Stress in Early Heart Disease
Asymptomatic dilated cardiomyopathy patients show abnormal opioid peptide responses to mental stress, with elevated ANF but normal baseline opioid levels.
Quick Facts
What This Study Found
Asymptomatic dilated cardiomyopathy patients had normal resting opioid peptide levels but showed altered opioid peptide responses to mental stress, alongside elevated ANF levels.
Key Numbers
How They Did This
Clinical study of 14 asymptomatic dilated cardiomyopathy patients undergoing mental arithmetic stress tests with placebo vs. naloxone, measuring plasma beta-endorphin, met-enkephalin, dynorphin B, norepinephrine, endothelin-1, and ANF.
Why This Research Matters
Understanding how the endogenous opioid system responds to stress in early heart disease could reveal biomarkers for disease progression and identify a role for opioid peptides in cardiovascular stress adaptation.
The Bigger Picture
The endogenous opioid system isn't just about pain — it plays important roles in cardiovascular regulation and stress response. Altered opioid peptide signaling in early heart disease may represent an adaptive mechanism or an early sign of the neurohumoral changes that drive heart failure progression.
What This Study Doesn't Tell Us
Small sample size (n=14). Only asymptomatic patients studied — may not generalize to symptomatic heart failure. Cross-sectional design doesn't establish causality.
Questions This Raises
- ?Do opioid peptide stress responses predict progression from asymptomatic to symptomatic heart failure?
- ?Is the altered opioid response protective or harmful in cardiac disease?
- ?Could opioid system modulation improve stress tolerance in cardiac patients?
Trust & Context
- Key Stat:
- 14 patients, altered stress response Asymptomatic cardiomyopathy patients showed abnormal opioid peptide patterns during mental stress despite normal resting levels
- Evidence Grade:
- Small clinical study with appropriate naloxone-controlled design. Hypothesis-generating but underpowered for definitive conclusions.
- Study Age:
- Published in 1998, part of early research connecting endogenous opioid systems to cardiovascular disease progression.
- Original Title:
- Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy.
- Published In:
- Peptides, 19(7), 1147-53 (1998)
- Authors:
- Fontana, F(8), Bernardi, P(8), Merlo Pich, E(2), Tartuferi, L, Boschi, S, De Iasio, R, Spampinato, S
- Database ID:
- RPEP-00460
Evidence Hierarchy
Frequently Asked Questions
What are endogenous opioid peptides?
They are natural painkillers produced by the body, including beta-endorphin, met-enkephalin, and dynorphin. Beyond pain control, they regulate stress responses, mood, and cardiovascular function.
Why study opioid peptides in heart disease?
The endogenous opioid system helps regulate heart rate, blood pressure, and stress responses. Changes in opioid peptide levels or responses may indicate early cardiovascular dysfunction before symptoms appear.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00460APA
Fontana, F; Bernardi, P; Merlo Pich, E; Tartuferi, L; Boschi, S; De Iasio, R; Spampinato, S. (1998). Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy.. Peptides, 19(7), 1147-53.
MLA
Fontana, F, et al. "Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy.." Peptides, 1998.
RethinkPeptides
RethinkPeptides Research Database. "Opioid peptides in response to mental stress in asymptomatic..." RPEP-00460. Retrieved from https://rethinkpeptides.com/research/fontana-1998-opioid-peptides-in-response
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.